ロード中...
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
Classical Hodgkin Lymphoma (cHL) is a B-cell malignancy that, typically, responds well to standard therapies. However, patients who relapse after standard regimens or are refractory to induction therapy have a dismal outcome. The implementation of novel therapies such as the anti-CD30 monoclonal ant...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862619/ https://ncbi.nlm.nih.gov/pubmed/31694167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20215503 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|